Matjaz Humar Selected Research

Barbiturates

4/2008	Thiopental protects human T lymphocytes from apoptosis in vitro via the expression of heat shock protein 70.
12/2004	Inhibition of activator protein 1 by barbiturates is mediated by differential effects on mitogen-activated protein kinases and the small G proteins ras and rac-1.
2/2004	Barbiturates directly inhibit the calmodulin/calcineurin complex: a novel mechanism of inhibition of nuclear factor of activated T cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matjaz Humar Research Topics

Disease

6	Neoplasms (Cancer) 11/2020 - 09/2004
5	Intracranial Hypertension 01/2013 - 05/2002
3	Inflammation (Inflammations) 01/2017 - 03/2008
3	Hyperthyroidism 12/2013 - 12/2007
3	Craniocerebral Trauma (Head Injury) 04/2008 - 05/2002
2	Brain Injuries (Brain Injury) 01/2013 - 02/2004
2	Neoplasm Metastasis (Metastasis) 04/2009 - 09/2004
2	Shock 04/2008 - 03/2006
2	Infections 09/2004 - 02/2004
1	Asthma (Bronchial Asthma) 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Hemorrhagic Stroke 12/2013
1	Retinoblastoma (Glioblastoma, Retinal) 02/2013
1	Fibrosis (Cirrhosis) 02/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2009
1	Neuroblastoma 03/2009
1	Traumatic Brain Injuries (Traumatic Brain Injury) 03/2009
1	Pneumonia (Pneumonitis) 04/2008
1	Wound Infection (Wound Infections) 04/2008
1	Ischemia 06/2007
1	Reperfusion Injury 06/2007
1	Hemorrhagic Shock 03/2006
1	Autoimmune Lymphoproliferative Syndrome 06/2005
1	Cross Infection (Nosocomial Infection) 12/2004
1	Critical Illness (Critically Ill) 11/2004

Drug/Important Bio-Agent (IBA)

5	Thiopental (Pentothal)FDA Link 01/2013 - 05/2002
3	Proteins (Proteins, Gene)FDA Link 01/2014 - 04/2008
3	BarbituratesIBA 04/2008 - 02/2004
2	CarbimazoleIBA 12/2013 - 03/2009
2	Anesthetics (Anesthetic Agents)IBA 06/2007 - 09/2004
2	Heme Oxygenase-1IBA 06/2007 - 03/2006
1	Particulate MatterIBA 11/2020
1	Aldehyde Dehydrogenase 1 FamilyIBA 01/2019
1	DuocarmycinsIBA 01/2019
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2019
1	CytokinesIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2014
1	VaccinesIBA 01/2014
1	Adenosine Triphosphate (ATP)IBA 12/2013
1	Oxygen (Dioxygen)IBA 12/2013
1	CollagenIBA 02/2013
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 02/2013
1	Cyclin D1IBA 02/2013
1	tricarbonyldichlororuthenium (II) dimerIBA 02/2013
1	Cyclin EIBA 02/2013
1	Cycloheximide (Cicloheximide)IBA 01/2013
1	DNA (Deoxyribonucleic Acid)IBA 04/2009
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 03/2009
1	Caspase 3 (Caspase-3)IBA 03/2009
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 03/2009
1	Transcription Factors (Transcription Factor)IBA 03/2009
1	CalciumIBA 03/2009
1	Small Interfering RNA (siRNA)IBA 04/2008
1	Iodide Peroxidase (Deiodinase)IBA 03/2008
1	NF-kappa B (NF-kB)IBA 03/2008
1	Mitogen-Activated Protein KinasesIBA 12/2007
1	CalcineurinIBA 12/2007
1	Isoflurane FDA LinkGeneric 06/2007
1	Messenger RNA (mRNA)IBA 03/2006
1	urapidilIBA 03/2006
1	DihydralazineIBA 03/2006
1	Vasodilator Agents (Vasodilators)IBA 03/2006
1	Sevoflurane (Ultane)FDA LinkGeneric 06/2005
1	Therapeutic UsesIBA 12/2004
1	Adrenergic Agents (Adrenergic Drugs)IBA 11/2004

Therapy/Procedure

2	Immunotherapy 01/2014 - 04/2009
1	Transplantation 01/2014
1	Anesthesia 04/2008
1	Therapeutics 03/2008
1	Resuscitation 03/2006
1	General Anesthesia 09/2004